IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 165 filers reported holding IMPAX LABORATORIES INC in Q4 2013. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $24,643,000 | -40.9% | 1,859,829 | +5.7% | 0.00% | -33.3% |
Q3 2016 | $41,691,000 | -16.4% | 1,759,121 | +1.7% | 0.01% | -25.0% |
Q2 2016 | $49,864,000 | -9.6% | 1,730,188 | +0.5% | 0.01% | -11.1% |
Q1 2016 | $55,133,000 | -23.3% | 1,721,824 | +2.4% | 0.01% | -25.0% |
Q4 2015 | $71,895,000 | +23.8% | 1,681,366 | +2.0% | 0.01% | +20.0% |
Q3 2015 | $58,064,000 | -24.8% | 1,649,071 | -1.9% | 0.01% | -16.7% |
Q2 2015 | $77,212,000 | -8.8% | 1,681,443 | -7.0% | 0.01% | -7.7% |
Q1 2015 | $84,701,000 | +48.1% | 1,807,155 | +0.1% | 0.01% | +44.4% |
Q4 2014 | $57,193,000 | +31.3% | 1,805,324 | -1.7% | 0.01% | +28.6% |
Q3 2014 | $43,543,000 | -23.3% | 1,836,462 | -2.9% | 0.01% | -22.2% |
Q2 2014 | $56,749,000 | +10.1% | 1,892,266 | -3.0% | 0.01% | 0.0% |
Q1 2014 | $51,521,000 | +8.4% | 1,950,085 | +3.2% | 0.01% | +12.5% |
Q4 2013 | $47,515,000 | +2.1% | 1,890,016 | -16.9% | 0.01% | -11.1% |
Q3 2013 | $46,555,000 | +24.9% | 2,274,287 | +21.7% | 0.01% | +12.5% |
Q2 2013 | $37,264,000 | – | 1,868,975 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 5,415,600 | $162,414,000 | 1.91% |
Broadfin Capital, LLC | 1,217,858 | $36,524,000 | 1.80% |
NEW AMSTERDAM PARTNERS LLC/NY | 695,100 | $20,846,000 | 1.36% |
Healthcare Value Capital, LLC | 50,000 | $1,500,000 | 1.26% |
Iguana Healthcare Management, LLC | 75,000 | $2,249,000 | 1.05% |
Matarin Capital Management, LLC | 78,292 | $2,347,977,000 | 1.04% |
Independence Capital Asset Partners, LLC | 253,089 | $7,590,000 | 1.04% |
Tekla Capital Management LLC | 344,683 | $10,337,000 | 0.95% |
Penn Capital Management Company, LLC | 794,641 | $23,831,000 | 0.92% |
Leonard Capital Management, Inc. | 87,661 | $2,629,000 | 0.89% |